Abstract
NSAIDs are widely used not only for systemic control of acute or chronic pain and inflammation, but also for ocular surface and anterior segment inflammation as a topical instillation. Bromfenac sodium is a NSAID approved for the treatment of postoperative inflammation and ocular inflammatory disorder (blepharitis, conjunctivitis and scleritis/episcleritis). Bromfenac ophthalmic solution has been demonstrated to be very effective for ocular inflammation with twice-daily instillation, resulting from preclinical and pharmacokinetic features. Bromfenac ophthalmic solution is well tolerated, and the incidence of serious adverse events is very low. These results demonstrate that bromfenac ophthalmic solution is clinically useful and a convenient ophthalmic NSAID.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
